Regards state employee reimbursement for GLP-1 drug costs

HB 388 requires state health plans to reimburse state employees and elected officials for costs associated with GLP-1 medications (used for conditions like diabetes or obesity). It adds these specific drugs to the list of covered expenses under existing reimbursement policies. The bill establishes a clear process for employees to seek reimbursement for these medications through their state health plan. This directly affects state workers who use GLP-1 drugs and ensures their costs are covered under state health benefits.